SBI-797812
Modify Date: 2024-01-14 12:12:38
SBI-797812 structure
|
Common Name | SBI-797812 | ||
|---|---|---|---|---|
| CAS Number | 2237268-08-3 | Molecular Weight | 402.47 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H22N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SBI-797812SBI-797812 is structurally similar to active-site directed NAMPT inhibitors and blocks binding of these inhibitors to NAMPT with EC50 of 0.37 μM. SBI-797812 shifts the NAMPT reaction equilibrium towards NMN formation, increases NAMPT affinity for ATP, stabilizes phosphorylated NAMPT at His247, promotes consumption of the pyrophosphate by-product, and blunts feedback inhibition by NAD+. Treatment of cultured cells with SBI-797812 increases intracellular NMN and NAD+. Dosing of mice with SBI-797812 elevates liver NAD+[1]. |
| Name | SBI-797812 |
|---|
| Description | SBI-797812 is structurally similar to active-site directed NAMPT inhibitors and blocks binding of these inhibitors to NAMPT with EC50 of 0.37 μM. SBI-797812 shifts the NAMPT reaction equilibrium towards NMN formation, increases NAMPT affinity for ATP, stabilizes phosphorylated NAMPT at His247, promotes consumption of the pyrophosphate by-product, and blunts feedback inhibition by NAD+. Treatment of cultured cells with SBI-797812 increases intracellular NMN and NAD+. Dosing of mice with SBI-797812 elevates liver NAD+[1]. |
|---|---|
| Related Catalog | |
| Target |
NAMPT[1] |
| References |
| Molecular Formula | C19H22N4O4S |
|---|---|
| Molecular Weight | 402.47 |